Article
L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells.
The Prostate - 1 Dec 2024
Hsieh Chia-Ling, Do Anh Duy, Hsueh Chia-Yen, Raboshakga Mafewu Olga, Thanh Tran Ngoc, Tai Tran Tien, Kung Hsing-Jien, Sung Shian-Ying
Abstract excerpt
BACKGROUND: A specific type of prostate cancer (PC) that exhibits neuroendocrine (NE) differentiation is known as NEPC. NEPC has little to no response to androgen deprivation therapy and is associated with the development of metastatic castration-resistant PC (CRPC), which has an extremely poor prognosis. Our understanding of genetic drivers and activated pathways in NEPC is limited, which hinders precision...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
